SWISS GOVERNMENT'S REPORT ON HOMEOPATHIC
MEDICINE:
COST-EFFECTIVE MEDICINE
The recent Swiss government's report on
homeopathic medicine represents the most comprehensive evaluation of
homeopathic medicine ever written by a government
The report was published last year in book
form in English (Bornhoft and Matthiessen, 2011). This breakthrough report
states that homeopathic treatment is both effective and cost-effective and
recommends that homeopathic treatment be reimbursed by Switzerland's national
health insurance program.
Some of the highlights of this report
are:
1/ The Swiss Government´s report on
Homeopathy is much more comprehensive than any previous governmental report
written on homeopathy to date. Not only does this report carefully review the
body of evidence from randomized double-blind and placebo controlled clinical
trials testing homeopathic medicines, but it also evaluates the "real
world effectiveness" as well as safety and cost-effectiveness.
2/ In terms of including empirical values,
the report also notes that David Sackett, M.D., the Canadian physician who is
widely considered to be one of the leading pioneers in "evidence based
medicine," has expressed serious concern about those researchers and
physicians who consider randomized and double-blind trials as the only means to
determine whether a treatment is effective or not. To make this assertion, one
would have to acknowledge that virtually all surgical procedures were
"unscientific" or "unproven" because so few have undergone
randomized double-blind trials.
2/ Also very interesting is how the
report found a particularly strong body of evidence to support the homeopathic
treatment of Upper Respiratory Tract Infections and Respiratory Allergies, an
area of pathology that conventional medicine has relative success with, outside
temporary suppression with antibiotics and corticoids.
3/ And finally, the mention of ‘cost effectiveness’ of homeopathy is essentially important given the incessant rising expense of national health bills and insurance costs.
For those who are interested in reading further, here is a summary of the report:
The Health Technology Assessment report
on effectiveness, cost-effectiveness and appropriateness of homeopathy was
compiled on behalf of the Swiss Federal Office for Public Health (BAG) within
the framework of the 'Program of Evaluation of Complementary Medicine (PEK)'.
MATERIALS AND METHODS:
Databases accessible by Internet were
systematically searched, complemented by manual search and contacts with
experts, and evaluated according to internal and external validity criteria.
RESULTS:
Many high-quality investigations of
pre-clinical basic research proved homeopathic high-potencies inducing
regulative and specific changes in cells or living organisms. 20 of 22
systematic reviews detected at least a trend in favor of homeopathy. In our
estimation 5 studies yielded results indicating clear evidence for homeopathic
therapy. The evaluation of 29 studies in the domain 'Upper Respiratory Tract
Infections/Allergic Reactions' showed a positive overall result in favor of
homeopathy. 6 out of 7 controlled studies were at least equivalent to
conventional medical interventions. 8 out of 16 placebo-controlled studies were
significant in favor of homeopathy. Swiss regulations grant a high degree of
safety due to product and training requirements for homeopathic physicians.
Applied properly, classical homeopathy has few side-effects and the use of
high-potencies is free of toxic effects. A general health-economic statement
about homeopathy cannot be made from the available data.
CONCLUSION:
Taking internal and external validity
criteria into account, effectiveness of homeopathy can be supported by clinical
evidence and professional and adequate application be regarded as safe.
Reliable statements of cost-effectiveness are not available at the moment.
External and model validity will have to be taken more strongly into
consideration in future studies.
This is the website where to find the full
Swiss government report,
http://www.ncbi.nlm.nih.gov/pubmed/16883077
susanaaikin gmail.com
No comments:
Post a Comment